US 11753461
Optimized factor VIII genes
granted A61KA61K38/00A61K48/0016
Quick answer
US patent 11753461 (Optimized factor VIII genes) held by BIOVERATIV THERAPEUTICS INC. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K48/0016, A61K48/005, A61P